Literature DB >> 33201005

Early Percutaneous Tracheostomy in Coronavirus Disease 2019: Association With Hospital Mortality and Factors Associated With Removal of Tracheostomy Tube at ICU Discharge. A Cohort Study on 121 Patients.

Antonio Rosano1, Enrico Martinelli, Federica Fusina, Filippo Albani, Rosalba Caserta, Alessandro Morandi, Piera Dell'Agnolo, Alessandra Dicembrini, Leila Mansouri, Andrea Marchini, Valeria Schivalocchi, Giuseppe Natalini.   

Abstract

OBJECTIVES: Early tracheotomy, defined as a procedure performed within 10 days from intubation, is associated with more ventilator free days, shorter ICU stay, and lower mortality than late tracheotomy. During the coronavirus disease 2019 pandemic, it was especially important to save operating room resources and to have a shorter ICU stay for patients, when ICUs had insufficient beds. In this context of limited resources, early percutaneous tracheostomy could be an effective way to manage mechanically ventilated patients. Nevertheless, current recommendations suggest delaying or avoiding the tracheotomy in coronavirus disease 2019 patients. Aim of the study was to analyze the hospital mortality of coronavirus disease 2019 patients who had received early percutaneous tracheostomy and factors associated with removal of tracheostomy cannula at ICU discharge.
DESIGN: Cohort study.
SETTING: Coronavirus disease 2019 ICU. PATIENTS: Adult patients with coronavirus disease 2019 3 days after ICU admission.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Three days after ICU admission, 164 patients were present in ICU and included in the analysis. One-hundred and twenty-one patients (74%) were tracheostomized, whereas the other 43 (26%) were managed with translaryngeal intubation only. In multivariable analysis, early percutaneous tracheostomy was associated with lower hospital mortality. Sixty-six of tracheostomized patients (55%) were discharged alive from the hospital. Age and male sex were the only characteristics that were independently associated with mortality in the tracheostomized patients (45.5% and 62.8% in tracheostomized and nontracheostomized patients, respectively; p = 0.009). Tracheostomy tube was removed in 47 of the tracheostomized patients (71%). The only variable independently associated with weaning from tracheostomy at ICU discharge was a faster start of spontaneous breathing after tracheotomy was performed.
CONCLUSIONS: Early percutaneous tracheostomy was safe and effective in coronavirus disease 2019 patients, giving a good chance of survival and of weaning from tracheostomy cannula at ICU discharge.
Copyright © 2020 by the Society of Critical Care Medicine and Wolters Kluwer Health, Inc. All Rights Reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33201005     DOI: 10.1097/CCM.0000000000004752

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  9 in total

1.  Update of the recommendations of the Sociedade Portuguesa de Cuidados Intensivos and the Infection and Sepsis Group for the approach to COVID-19 in Intensive Care Medicine.

Authors:  João João Mendes; José Artur Paiva; Filipe Gonzalez; Paulo Mergulhão; Filipe Froes; Roberto Roncon; João Gouveia
Journal:  Rev Bras Ter Intensiva       Date:  2022-01-24

2.  Tracheostomy in COVID-19 Patients: Experience at a Tertiary Center in the First 11 Months of the Pandemic.

Authors:  Luís Roque Reis; Luís Castelhano; Kaamil Gani; Gustavo Almeida; Pedro Escada
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2021-08-15

3.  POINT: Tracheostomy in Patients With COVID-19: Should We Do It Before 14 Days? Yes.

Authors:  Michael J Brenner; David Feller-Kopman; Jose De Cardenas
Journal:  Chest       Date:  2021-02-27       Impact factor: 9.410

4.  Tracheostomy in COVID-19 acute respiratory distress syndrome patients and follow-up: A parisian bicentric retrospective cohort.

Authors:  Diane Evrard; Igor Jurcisin; Maksud Assadi; Juliette Patrier; Victor Tafani; Nicolas Ullmann; Jean-François Timsit; Philippe Montravers; Béatrix Barry; Emmanuel Weiss; Sacha Rozencwajg
Journal:  PLoS One       Date:  2021-12-22       Impact factor: 3.240

5.  Suspension laryngoscopy-assisted percutaneous dilatational tracheostomy: a safe method in COVID-19.

Authors:  Franco Parmigiani; Antonello Alberto Sala; Cristiana Fumanti; Andrea Luigi Rescaldani; Federico Giuseppe Quarta; Stefano Carlo Paradisi
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-10       Impact factor: 2.124

6.  Coronavirus Disease 2019 Tracheostomy Candidacy, Ceteris Paribus Assumptions, and Tracking Survivorship Data.

Authors:  Michael J Brenner; David J Feller-Kopman; Paolo Pelosi
Journal:  Crit Care Med       Date:  2022-03-01       Impact factor: 9.296

7.  Tracheostomy Practices and Outcomes in Patients With COVID-19 Supported by Extracorporeal Membrane Oxygenation: An Analysis of the Extracorporeal Life Support Organization Registry.

Authors:  Joseph G Kohne; Graeme MacLaren; Leigh Cagino; Philip S Boonstra; Daniel Brodie; Ryan P Barbaro
Journal:  Crit Care Med       Date:  2022-05-16       Impact factor: 9.296

Review 8.  Systematic review and meta-analysis of tracheostomy outcomes in COVID-19 patients.

Authors:  A Ferro; S Kotecha; G Auzinger; E Yeung; K Fan
Journal:  Br J Oral Maxillofac Surg       Date:  2021-05-18       Impact factor: 1.651

9.  Association of Tracheostomy With Outcomes in Patients With COVID-19 and SARS-CoV-2 Transmission Among Health Care Professionals: A Systematic Review and Meta-analysis.

Authors:  Phillip Staibano; Marc Levin; Tobial McHugh; Michael Gupta; Doron D Sommer
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2021-07-01       Impact factor: 8.961

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.